Viking Therapeutics Newsroom

Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Raises Target Price to $164

Moomoo NewsNov 14 08:31 ET · Ratings

Oppenheimer Sticks to Their Buy Rating for Viking Therapeutics (VKTX)

TipRanksNov 14 07:58 ET · Ratings

Eli Lilly and Co. is startled, novo-nordisk a/s saves the day! The market prospects for weight loss drugs still tempt many players.

The weight loss drug market still has a broad prospect, with most institutions predicting that the market size will reach the trillion-dollar level by the end of this decade.

Zhitong FinanceNov 14 01:45 ET

10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaNov 13 12:35 ET

Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?

Yahoo FinanceNov 13 09:45 ET

Viking Therapeutics to Present Data From Phase 2b VOYAGE Study of VK2809 in Patients With Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024

PR NewswireNov 12 16:05 ET

Is Viking Therapeutics a Buy on the Dip?

Yahoo FinanceNov 10 05:15 ET

4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move

Yahoo FinanceNov 8 07:10 ET

Peace Medical Acquired by Experienced Healthcare Professional, Ensuring Continuity and Growth

PR NewswireNov 7 15:10 ET

Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag

Yahoo FinanceNov 7 10:15 ET

Viking Therapeutics (VKTX) Stock Surges on Promising Treatment Pipeline

TipRanksNov 6 03:29 ET

Viking Therapeutics Offers An Obesity Drug for Healthy Adults

Yahoo FinanceNov 5 13:02 ET

Viking Therapeutics Participates in a Conference Call With JPMorgan

TipRanksNov 5 10:35 ET

Express News | HC Wainwright & Co. Maintains Buy on Viking Therapeutics, Raises Price Target to $102

BenzingaNov 5 09:17 ET

Viking Therapeutics Analyst Ratings

BenzingaNov 5 09:15 ET · Ratings

Daily short sale tracking: Viking Therapeutics's short volume increased by 3 million, with a short sale ratio of 14%

Moomoo NewsNov 5 09:00 ET

A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $118

Moomoo NewsNov 5 08:00 ET · Ratings

Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Palantir Technologies, Hims & Hers Health to Open Higher

MT NewswiresNov 5 07:26 ET

Viking Therapeutics (VKTX.US) weight loss drug emerges as a dark horse, challenging the dominance of the 'Norlevo Brothers'.

Data released earlier on Monday by viking therapeutics shows that novo-nordisk a/s and eli lilly and co, currently dominating the obesity drug field, may face fierce competition in the future.

Zhitong FinanceNov 4 21:39 ET

Why Viking Therapeutics Stock Plummeted After Soaring Today

Yahoo FinanceNov 4 18:33 ET